MRNA

NASDAQ · Biotechnology

Moderna Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$154.04

-4.03 (-2.55%)

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 11 37%

Hold 17 57%

Sell 2 7%

Price Target

Analyst Price Target -3.0% upside

Low Target $89.97

Average Target $149.45

High Target $212.09

Current Price $154.04

Current
$154.04

Target
$149.45

$89.97 $149.45 avg $212.09

Scenario Analysis

Bear Case

$89.97

-41.6%

Low target

Base Case

$149.45

-3.0%

Avg target

Bull Case

$212.09

+37.7%

High target

Risk/Reward

0.9x

Unfavorable

Price in Context

52-Week High

$176.66

-12.8% from high

52-Week Low

$22.28

+591.4% from low

50-Day SMA

$37.98

+305.6% vs SMA

200-Day SMA

$29.64

+419.7% vs SMA

RSI (14)

57.2

Neutral

Target vs 52W High

$149.45

-15.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.4%
AMGN Amgen Inc	Hold	43	47%	$190.87	-50.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-3.0%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%